Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treating cancer's kinase 'addiction'.

× No keyword cloud information.

11 in total

1. Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker.

Authors: Irene Sulzbacher; Peter Birner; Cyril Toma; Nikolaus Wick; Peter R Mazal
Journal: J Clin Pathol Date: 2006-10-03 Impact factor: 3.411

2. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.

Authors: Amos Gaikwad; Roberto Nussenzveig; Enli Liu; Stephen Gottshalk; KoTung Chang; Josef T Prchal
Journal: Exp Hematol Date: 2007-04 Impact factor: 3.084

3. 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.

Authors: Anuradha Soundararajan; Jinu Abraham; Laura D Nelon; Suresh I Prajapati; Lee Ann Zarzabal; Joel E Michalek; Stanton F McHardy; Douglas S Hawkins; Suman Malempati; Charles Keller
Journal: Pediatr Blood Cancer Date: 2012-01-11 Impact factor: 3.167

4. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl.

Authors: Zhongzheng Lu; Yanli Jin; Chun Chen; Juan Li; Qi Cao; Jingxuan Pan
Journal: Mol Cancer Date: 2010-05-19 Impact factor: 27.401

5. Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression.

Authors: Srinivasan Yegnasubramanian; Anirban Maitra
Journal: Cancer Discov Date: 2013-03 Impact factor: 39.397

6. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.

Authors: Marcus P Kelly; Sze Ting Lee; F-T Lee; Fiona E Smyth; Ian D Davis; Martin W Brechbiel; Andrew M Scott
Journal: Prostate Date: 2009-01-01 Impact factor: 4.104

7. Outlier kinase expression by RNA sequencing as targets for precision therapy.

Authors: Vishal Kothari; Iris Wei; Sunita Shankar; Shanker Kalyana-Sundaram; Lidong Wang; Linda W Ma; Pankaj Vats; Catherine S Grasso; Dan R Robinson; Yi-Mi Wu; Xuhong Cao; Diane M Simeone; Arul M Chinnaiyan; Chandan Kumar-Sinha
Journal: Cancer Discov Date: 2013-02-05 Impact factor: 39.397

8. The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.

Authors: Jingui Ma; Xianliang Xin; Linghua Meng; Linjiang Tong; Liping Lin; Meiyu Geng; Jian Ding
Journal: PLoS One Date: 2008-11-20 Impact factor: 3.240

9. Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profile.

Authors: Jin Long; Zhe Liu; Xingda Wu; Yuanhong Xu; Chunlin Ge
Journal: Mol Med Rep Date: 2016-03-18 Impact factor: 2.952

10. Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera.

Authors: Amos Gaikwad; Josef T Prchal
Journal: Exp Hematol Date: 2007-11 Impact factor: 3.084